HomeAQST • NASDAQ
add
Aquestive Therapeutics Inc
Previous close
$2.38
Day range
$2.34 - $2.48
Year range
$2.12 - $5.80
Market cap
236.40M USD
Avg Volume
1.53M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 8.72M | -27.65% |
Operating expense | 24.43M | 47.00% |
Net income | -22.93M | -78.75% |
Net profit margin | -262.96 | -147.07% |
Earnings per share | -0.22 | -49.00% |
EBITDA | -19.23M | -119.73% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 68.66M | -27.88% |
Total assets | 102.23M | -21.07% |
Total liabilities | 163.16M | -1.60% |
Total equity | -60.93M | — |
Shares outstanding | 99.33M | — |
Price to book | -3.90 | — |
Return on assets | -47.54% | — |
Return on capital | 220.32% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -22.93M | -78.75% |
Cash from operations | -23.40M | -125.35% |
Cash from investing | -135.00K | -365.52% |
Cash from financing | 20.65M | -74.74% |
Net change in cash | -2.89M | -104.05% |
Free cash flow | -14.87M | -188.66% |
About
Founded
2004
Headquarters
Website
Employees
142